Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Silverstein MicroWick.

Herbert Silverstein1, Jack Thompson, Seth I Rosenberg

  • 1Silverstein Institute, Ear Research Foundation, 1901 Floyd Street, Sarasota, FL 34239, USA. hsilverste@aol.com

Otolaryngologic Clinics of North America
|October 12, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

UGT1A1 genotype testing for irinotecan: A guideline developed by the UK Centre of Excellence in Regulatory Science and Innovation in Pharmacogenomics (CERSI-PGx).

British journal of clinical pharmacology·2026
Same author

The Effects of Forecasts on the Accuracy and Precision of Expectations.

Public opinion quarterly·2025
Same author

Minimally invasive surgery for hyperacusis-enhanced round and oval window reinforcement procedure.

American journal of otolaryngology·2025
Same author

Pharmacogenetics and adverse drug reports: Insights from a United Kingdom national pharmacovigilance database.

PLoS medicine·2025
Same author

Homologous recombination deficiency testing in patients with high grade ovarian cancer: factors influencing test success.

Future oncology (London, England)·2024
Same author

Oval and round window reinforcement surgery leads to improvements in sound tolerance and quality of life for hyperacusis patients.

American journal of otolaryngology·2024
Same journal

Obesity and Obstructive Sleep Apnea: Impact on Medical and Surgical Management.

Otolaryngologic clinics of North America·2026
Same journal

Little Tube; Big Problems: Eustachian Tube Dysfunction.

Otolaryngologic clinics of North America·2026
Same journal

Current State of Button Battery Ingestion Injuries.

Otolaryngologic clinics of North America·2026
Same journal

Diagnostic Algorithm for Eustachian Tube Dysfunction and Indications for Balloon Dilation of the Eustachian Tube.

Otolaryngologic clinics of North America·2026
Same journal

Patulous Eustachian Tube Dysfunction.

Otolaryngologic clinics of North America·2026
Same journal

Revisiting Eustachian Tube Anatomy and Physiology.

Otolaryngologic clinics of North America·2026
See all related articles

A novel MicroWick device offers a safe, effective, and inexpensive self-treatment for inner ear diseases. This breakthrough allows direct otic medication delivery, potentially improving hearing loss, vertigo, and tinnitus.

Area of Science:

  • Otolaryngology
  • Drug Delivery Systems
  • Inner Ear Therapeutics

Background:

  • Inner ear diseases present significant treatment challenges.
  • Current treatment methods for inner ear conditions are often invasive or lack direct drug delivery.
  • A need exists for effective, patient-administered therapies for otic conditions.

Purpose of the Study:

  • To introduce and evaluate the MicroWick as a novel method for delivering otic medication to inner ear fluids.
  • To establish the MicroWick as a safe, effective, and inexpensive self-treatment for inner ear disease.
  • To highlight the potential of the MicroWick for future otic drug development.

Main Methods:

  • Utilizing the MicroWick device for direct otic medication administration.
  • Targeting medication delivery to inner ear fluids via the round window membrane.

Related Experiment Videos

  • Developing a self-treatment approach for otic conditions.

    • Main Results:

    • The MicroWick provides a new, unique, effective, safe, efficient, and inexpensive method for treating inner ear disease.
    • This self-treatment method represents a major breakthrough in otic disease management.
    • The MicroWick facilitates otic medication delivery comparable to ophthalmic eye drop administration.

    Conclusions:

    • The MicroWick device enables direct self-administration of otic medications to the inner ear.
    • Future medications delivered via MicroWick may alleviate vertigo, improve sensorineural hearing loss, and reduce tinnitus.
    • This innovative approach holds significant promise for advancing the treatment of inner ear disorders.